ASSETMARK, INC

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1344551 CONCORD, CA

Position in ADPT

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$49,222

+$49,222 QoQ

Shares Held

2,295

+107.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#43

of 70 holders

Holding Since

Mar 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ASSETMARK, INC holds $185,901,617 across 24 Diagnostics & Research names. ADPT ranks #19 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IQV	Iqvia Holdings Inc.	197,012	$38,066,658
2	TMO	Thermo Fisher Scientific Inc.	66,520	$33,350,467
3	A	Agilent Technologies, Inc.	214,808	$28,532,946
4	IDXX	Idexx Laboratories Inc /De	46,428	$24,441,556
5	LH	Labcorp Holdings Inc.	80,594	$22,566,320
6	CRL	Charles River Laboratories International, Inc.	61,463	$13,939,193
7	DHR	Danaher Corp /De/	46,092	$8,779,604
8	NTRA	Natera, Inc.	18,343	$4,979,207

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$49,222	9,179	+107.6%	Shares	Sole	2026-07-30
2026-03-31	—	4,421	+46.4%	Shares	Sole	2026-05-06
2025-12-31	—	3,020	+867.9%	Shares	Sole	2026-01-23
2025-09-30	—	312	+55.2%	Shares	Sole	2025-11-06
2025-06-30	—	201	+151.2%	Shares	Sole	2025-08-04
2024-03-31	—	80	-98.4%	Shares	Sole	2024-05-07
2023-12-31	—	4,941	+43.5%	Shares	Sole	2024-02-09
2023-09-30	—	3,443	-15.3%	Shares	Sole	2023-10-27
2023-06-30	—	4,065	+56.2%	Shares	Defined	2023-08-11
2023-03-31	—	2,603	+28.4%	Shares	Defined	2023-05-05
2022-12-31	—	2,028	+44.5%	Shares	Defined	2023-02-10
2022-09-30	—	1,403	+30.9%	Shares	Sole	2022-11-01
2022-06-30	—	1,072	+337.6%	Shares	Sole	2022-08-03
2022-03-31	—	245	+469.8%	Shares	Sole	2022-05-13
2021-03-31	—	43	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.